baber/WOPTO huggingface dataset:
Patent IE-36498-L (IE)
Title: Storage heater
IPC: F28D20/02
Filed: 1972-06-21
Abstract: 1347609 Thermal storage heaters PHILIPS GLOEILAMPENFABRIEKEN NV 21 June 1972 [24 June 1971] 29032/72 Heading F4U A thermal storage heater which may be used for warm air heating or heating air for an oven comprises a double-walled container the thermally insulating space 11 provided therebetween housing one or more radiation screens 4 and containing a hydrogen atmosphere whose pressure is regulated by the temperature of a reservoir 6 containing a reversible hydrogen getter material 7, e.g. partially hydrogenated zirconium and a controllable heating element. The heater may have a fan 10 for forced convective flow or its acts simply by radiation and normal convection. The heat storage material 1 may be a block of high melting point material or a material such as lithium fluoride which fuses during heating and gives it latent heat during cooling. The material is heated by an electric heater 5. In another form there are two compartments each having a controllable hydrogen atmosphere, one regulating heat transfer to an oven, the other regulating heat transfer for space heating.
Patent IE-33417-L (IE)
Title: Cephalosporin sulphoxide
IPC: C07D501/04
Filed: 1969-07-01
Abstract: 1,260,698. Cephalosporin sulphoxides ELI LILLY & CO. 24 July, 1969 [21 Jan., 1969], No. 37373/69. Heading C2A. Novel cephalosporin sulphoxides having the formula wherein R is triphenylmethyl, butoxycarbonyl, trimethylsilyl or an acyl group having the formula wherein Z is oxygen or a chemical bond, m is an integer of 0 to 4 inclusive, and n is an integer of 1 to 4 inclusive, the methylene groups being optionally substituted by 1 or 2 methyl groups, and such acyl groups substituted on phenyl carbon atoms with fluorine, chlorine, bromine, iodine, C 1 to C 6 alkyl, C 1 to C 6 alkoxy, nitro, cyano, or trifluoromethyl groups; R<SP>1</SP> is hydrogen, C 4 to C 6 tertiary alkyl, C 5 to C 8 tertiary alkenyl, C 5 to C 8 tertiary alkynyl, benzyl, methoxybenzyl, nitrobenzyl, benzhydryl, phthalimidomethyl, succinimidomethyl, trimethylsilyl, or phenacyl; and X is -CN or -OR<SP>11</SP>, wherein R<SP>11</SP> is hydrogen, C 1 to C 10 alkyl, C 3 to C 10 alkenyl, C 3 to C 10 alkynyl, C 5 to C 7 cycloalkyl, C 5 to C 7 cycloalkyl-C 1 to C 3 alkyl, C 2 to C 10 haloalkyl, C 3 to C 10 haloalkenyl, C 3 to C 10 haloalkynyl, C 1 to C 3 alkyl-O-C 2 to C 6 alkyl, C 2 to C 4 alkanoyloxy-C 2 to C 6 alkyl, C 1 to C 6 alkoxycarbonyl-C 1 to C 6 alkyl, cyano-C 2 to C 6 alkyl, C 2 to C 4 alkanoyl-C 1 to C 4 alkyl, tetrahydrofuryl-C 1 to C 3 alkyl, 3<SP>1</SP>-tetrahydrofuryl, furyl-C 0 to C 2 alkyl, thienyl-C 1 to C 3 alkyl, or phenyl-C 1 to C 3 alkyl which may be substituted on phenyl carbon atoms with halogen, trifluoromethyl, cyano, C 1 to C 3 alkoxy, C 1 to C 3 alkyl, nitro, or carbo-C 1 to C 3 alkoxy; are prepared by reacting a corresponding cephalosporin with an oxidizing agent selected from an inorganic peroxide having a reduction potential of at least +1À50 and containing only non-metallic elements, an organic carboxylic peracid and a mixture of hydrogen peroxide and an acid having a dissociation constant of at least 10<SP>-5</SP>.
[GB1260698A]
Patent IE-40930-L (IE)
Title: Decapeptides
IPC: C07K14/575
Filed: 1974-10-01
Abstract: 1458685 Decapeptides AMERICAN HOME PRODUCTS CORP 25 Sept 1974 [3 Oct 1973 21 Nov 1973] 41612/74 Heading C3H Peptides of Formula (I) wherein X is Ala or Leu, and the non-toxic salts thereof (hydrocholoride, hydrobromide, sulphate, phosphate, maleate, acetate, citrate, benzoate, succinate, malate or ascorbate). Derivatives of (I) of Formula (II) wherein N<SP>9</SP> represents side chain nitrogen atoms of Arg, R is NH 2 , OH, O-(lower)alkyl ("lower" being C 1-6 ), O-benzyl, R<SP>1</SP> is a protecting group for the N<SP>8</SP>, N<SP>#</SP>, N<SP>#1</SP> atoms of Arg, and is nitro, tosyl, benzyloxycarbonyl or adamantyloxycarbonyl (if R<SP>1</SP> is nitro or tosyl, protection is on either the N<SP>#</SP> or N<SP>#1</SP> and, if R<SP>1</SP> is benzyloxycarbonyl or adamantyloxycarbonyl, protection is on N<SP>#</SP> and either N<SP>#</SP> or N<SP>#1</SP>); R<SP>2</SP> is a protecting group for the phenolic hydroxyl of Tyr and is acetyl, tosyl, benzoyl, t-butyl, tetrahydropyranyl, trityl, benzyl, 2,4-dichlorobenzyl or benzyloxycarbonyl; R<SP>3</SP> is a protecting group for the alcoholic hydroxyl of Ser and is one specified for R<SP>2</SP>; R<SP>4</SP> is an aminoprotecting group or hydrogen; wherein R<SP>1</SP>, R<SP>2</SP> or R<SP>3</SP> may also be hydrogen, with the proviso that at least one of R<SP>1</SP>, R<SP>2</SP> and R<SP>3</SP> is a protecting group and the non-toxic salts thereof. Derivatives of (II) of Formula (III) wherein R<SP>5</SP> is R<SP>4</SP>-(Pry)Glu, an α-aminoprotecting group or hydrogen; and A represents one of Preferred resins are benzhydrilamine, chloromethylated or hydroxymethyl styrene resins. The peptides may be prepared by Merrifield synthesis, to yield (III), followed by either (i) a one step cleavage and deprotection to yield (I) or (ii) cleavage to yield (II) followed by deprotection. Step (i) may be effected with hydrogen fluoride using benzhydrilamine resin, and step (ii) ammonolysis using a chloromethylated or hydroxymethyl resin. In the examples, the following peptides were prepared: H-(Pyr)Glu-D-Phe-Trp- Ser(Bzl) - Tyr(Bzl) - D - Ala - Leu- Arg(NO 2 ) - Pro - Gly benzhydrilamine resin; H - (Pyr)Glu - D - Phe - Trp - Ser- Tyr - D - Ala - Leu - Arg - Pro - Gly- NH 2 and acetate; H-(Pyr)Glu-D-Phe- Trp - Ser(Bzl) - Tyr(Bzl) - D - Leu- Leu - Arg(NO 2 ) - Pro - Gly benzhydrilamine resin; H - (Pyr)Glu - D - Phe - Trp- Ser - Tyr - D - Leu - Leu - Arg - Pro- Gly.NH 2 and acetate. Pharmaceutical compositions, for the inhibition of ovulation in female mammals, comprises a peptide of Formula (I) or a non-toxic salt thereof and a pharmaceutically acceptable carrier, said composition may be in unit dosage form.
[GB1458685A]
Patent IE-882051-L (IE)
Title: Making amino-methylene phosphonoalkylphosphinates compounds
IPC: C07F9/547
Filed: 1988-07-05
Abstract: The present invention involves processes for making aminomethylene phosphonoalkylphosphinate compounds comprising:   (a) heating a substantially anhydrous mixture comprising an amine, an ester of an alkyl phosphite, and an ester of a phosphate acetyl; and then   (b) adding water to the mixture. s
Patent IE-892293-L (IE)
Title: Pyrrolidinyl-3-quinolone and naphthyridone- carboxylic acid¹derivatives
IPC: A23K20/195
Filed: 1989-07-14
Abstract: 7-(1-Pyrrolidinyl)-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid and 7-(1-pyrrolidinyl)-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylic derivs. of formula (I), their hydrates, acid addition salts, as well as their alkali metal, alkaline earth, silver and guanidinium salts are new; X<1> = halo; X<2> = H, NH2, 1-4C alkylamino, di(1-3C alkyl)amino, OH, 1-4C alkoxy, SH, 1-4C alkylthio, arylthio or halo; R<1> = 1-4C alkyl, 2-4C alkenyl, 3-6C cycloalkyl, 2-hydroxyethyl, 2-fluoroethyl, OMe, NH2, MeNH, EtNH or Me2N; or is Ph (opt. mono- or disubstd. by F); R<2> = H, 1-4C alkyl or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl; R<3> = a gp. of formula (a): R<4> = 1-4C alkyl, aryl or 1-4C acyl; R<5> = H, 1-4C alkyl, OH or OMe; R<6> = H, 1-4C alkyl (opt. substd. by OH), aryl, heteroaryl, benzyl, 1-4C alkoxycarbonyl, 1-4C acyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or 3-6C cycloalkyl; R<7> = H or 1-4C alkyl; R',R'' = H, Me or Ph; R''' = H or Me; Y = O, CH2, CH2CH2 or CH2O (where the bond to N may be via C as well as O); (Note: Y is not otherwise defined in claim 1). Z = O or S; A = N or CR<8>; R<8> = H, halo, Me, CN, NO2 or OH, or R<8>+R<1> = a bridge of type (b)-(d): Cpds. of formula (e) are excluded; R1 = 1-4C alkyl; R2,R3 = H or 1-4C alkyl; R4 = cyclopropyl, Ph, halophenyl, thienyl, opt. substd. by 1-4C alkyl or halo; R5 = halo. Also claimed is the S,S-configuration of a cpd. of formula (f) and its salts:A = CCl, CF or COMe.
Patent IE-41529-L (IE)
Title: Indene acetic acids
IPC: C07C315/04
Filed: 1974-12-12
Abstract: 5-Fluoro-2-methyl-1-(p-methylsulphinylbenzylidene)indenyl-3-acetic acid or its salts are prepared. The said acid is obtained by condensing 5-fluoro-2-methyl-1-R1-benzylindene, where R1 is p-methylthio or p-methylsulphinyl, with glyoxylic acid, its salt or ester to give the corresponding 5-fluoro-2-methyl-1-(p-methylthio- (or methylsulphinyl)benzyl)indenylidene-3-acetic acid, its salt or ester. If R1 is p-methylsulphinyl, the indenylidene compound is isomerised to indenyl-3-acetic acid. If R1 denotes methylthio, then the resulting indenylidene-3-acetic acid is isomerised to 5-fluoro-2-methyl-1-(p-methylthiobenzylidene)indenyl-3-acetic acid and the p-methylthio radical is then oxidised to the p-methylsulphinyl group. However, the oxidation can also be carried out first and the isomerisation subsequently. The said compounds can be used as active agents in anti-inflammatory medicaments.
[GB1479519A]
Patent IE-862724-L (IE)
Title: Aerosol can
IPC: B65D83/44
Filed: 1986-10-15
Abstract: The valve (18) of an aerosol can (10) is actuated by a lever (38) having a handle portion (40) and an intermediate portion (42) bearing on a lock member (28). The lever (38) is pivotably mounted in a clip (30). The lock member (28) is in screw-threaded engagement with the valve (18) for movement therealong between closed (Fig. 1) and open (Fig. 6) positions. The lock member (28) can be placed in any intermediate position to set a desired flow rate through the valve (18) when the lever (38) is depressed by the user.
[WO8702335A1]
Patent IE-823020-L (IE)
Title: Anti-inflammatory ophthalmic solution
IPC: A61K9/00
Filed: 1982-12-20
Abstract: PURPOSE:An ophthalmic liquid solution, containing 2-(2-fluoro-4-biphenylyl)propionic acid and beta-or gamma-cyclodextrin or further a viscous agent, having greatly reduced irritant action, and stable for a long term without side effects. CONSTITUTION:The titled solution containing (A) 2-(2-fluoro-4-biphenylyl)propionic acid of the formula or a salt thereof and (B) beta-or gamma-cyclodextrin at 1:(0.5-1.5) molar ratio or further a viscous agent. The concentration of the component (A) in the solution is 0.001-2W/V%, and the pH of the solution is adjusted with a buffer agent to 5.0-8.0. In preparing the solution, the components (A) and (B), or a clathrate compound thereof, or a clathrate compound of the components (A) with (B) is dissolved in a water medium. The resultant solution is capable of solubilizing the component (A) in a high concentration, and therefore the inhibitory action on intraocular prostaglandins (PGs) and the mydriatic effect are more remarkable to give the marked effect on surgical operations, etc.
[JP58126810A]
Patent IE-813055-L (IE)
Title: Indole -dihydroindole alkaloid derivatives
IPC: A61P35/00
Filed: 1981-12-23
Abstract: 20'-Hydroxy derivatives of VLB, leurosidine and vincristine, antimitotic agents.
[US4320058A]
Patent IE-863092-L (IE)
Title: Dihydropyridine derivatives.
IPC: C07D211/00
Filed: 1983-03-10
Abstract: Dihydropyridines of the formula:- …<CHEM>… and their pharmaceutically acceptable acid addition salts… wherein Y is -(CH2)2-, -(CH2)3-, -CH2CH(CH3)- or -CH2C(CH3)2-;… R is aryl or heteroaryl;… R<1> and R<2> are each independently C1-C4 alkyl or 2-methoxyethyl; and… R<3> is hydrogen, C1-C4 alkyl, 2-(C1-C4 alkoxyl) ethyl, cyclopropylmethyl, benzyl, or -(CH2)mCOR<4> where m is 1, 2 or 3 and R<4> is hydroxy, C1-C4 alkoxy or - NR<R>5<6> where R<5> and R<6> are each independently hydrogen or C1-C4 alkyl, pharmaceutical compositions containing them, and processes for their production. …<??>The compounds are particularly useful in the treatment or prevention of a variety of cardiac conditions, e.g, angina pectoris. 
[EP0089167A2]
Patent IE-940431-L (IE)
Title: System and method for determination of the strength of sheet materials
IPC: G01N3/08
Filed: 1987-07-17
Abstract: A system and method are disclosed which provide a determination of the strength of paper or other sheet materials. The method used is not destructive and can be used to make measurements <<on-line>> while, for example, the paper sheet is being manufactured. A sensor senses a pheripheral characteristic of the sheet which is related to the elastic modulus and bending stiffness of the sheet and generates electrical signals corresponding thereto. A computer calculates a strength value for the sheet based upon the these electrical signals. This computed strenght value may be correlated with <<Mullen>> and other standardized strength tests.
[EP0253644A2]
Patent NO-781151-L (NO)
Title: Fremgangsmaate til fjerning av cyanidanioner fra fluider
Inventor: AVERY NOYES LATHAM
IPC: B01J41/04
Filed: 1978-04-03
Abstract: Fremgangsmåte til fjerning av cyanidanioner fra, væsker. , .
Patent NO-811161-L (NO)
Title: 3,8-dialkylxantiner og fremgangsmaate for deres fremstilling
Inventor: KJELLIN PER GUNNAR
IPC: C07D473/06
Filed: 1981-04-03
Abstract: Forbindelser med aktivitet mot kronisk obstruktiv luftveissykdom eller hjertekarsykdom, og disse forbindelser er kjennetegnet ved formelen:. hvor R^" er etyl, n-propyl, n-butyl, isobutyl, n-pentyl, 2-metylbutyl, 3-metylbutyl, 2,2-dimetylpropyl, cyklopropyl, cyklobutyl, cyklopentyl eller cykloheksylmetyl, og R 2 er metyl, etyl, n-propyl, isopropyl, cyklopropyl, n-butyl, 'isobutyl, tert.-butyl eller. 1 2. cyklobutyl forutsatt at R er etyl nar R er metyl,. eller et fysiologisk akseptabelt salt derav. Det be-skrives også fremgangsmåter til fremstilling av disse forbindelser, et farmasøytisk preparat inneholdende en av forbindelsene, samt en metode for behandling av kronisk obstruktiv luftveissykdom og hjertekarsykdom.
Patent NO-824378-L (NO)
Inventor: BURBA CHRISTIAN
IPC: C08G18/10
Filed: 1982-12-27
Abstract: The method of hardening a glycidyl compound with a polyether urethane urea amino hardener is disclosed, said hardener being prepared by reacting (1) a blocked prepolymer prepared by reacting a phenolic compound with the reaction product of a polyether polyol with an excess of polyisocyanate, with (2) a polyfunctional amino compound.
Patent NO-830491-L (NO)
Title: Oralt anti-diabetisk preparat.
Inventor: GANLEY JOHN ANTHONY
IPC: A61K9/48
Filed: 1983-02-14
Abstract: Farmasøytisk preparat som omfatter et stivt skall inneholdende et intrinsikalt kort-virkende oralt j anti-diabetisk sulfonylurinstoff-derivat i bland- i ing med en farmasøytisk godtagbar flytende bærer,. idet bæreren omfatter en varm smelte med et smeltepunkt innen området fra 2 5°C til en temperatur under den hvorved det bevirkes termisk ødeleggelse på skallet. Det omtales også en fremgangsmåte. til preparatets fremstilling.
Patent NO-844375-L (NO)
Inventor: BECK DONALD
IPC: E21B43/22
Filed: 1984-11-02
Abstract: A composition for use in enhanced oil recovery comprising from about 1.5-20 weight percent Xanthomonas biopolymer and from about 0.0008-3 weight percent methylene bis (thiocyanate), the composition having a pH above about 3.5. Also disclosed is a novel process for production of directly injectable biopolymer solution and a method for the recovery of crude oil from an oil-bearing subterranean formation by injecting the diluted composition into the formation.
Patent NO-853921-L (NO)
Inventor: HERKERT HANS
IPC: H04Q9/00
Filed: 1985-10-03
Abstract: In a transmission network having a tree structure in which data is forwarded from the tree branches toward the trunk at periodic intervals, the data which is transmitted between the several network levels is transmitted in data blocks each having a status field and a data field, the status field identifying the status of stations at a lower level in the network. The information in the status field is reduced by deleting data corresponding to a predetermined status information content corresponding to the most probable configuration of such data. The remaining status data is divided into sub-sets and transmitted with an individual sub-address for each sub-set, and a control signal identifying the number of sub-sets which are transmitted, and an address identifying the sending station.
Patent NO-854565-L (NO)
Inventor: TAKEDA MIKIO
IPC: C07D281/10
Filed: 1985-11-15
Abstract: Novel 1,5-benzothiazepine derivative of the formula:wherein R<sup>1</sup> is hydrogen or lower alkanoyl and each of R<sup>2</sup> and R<sup>3</sup> is lower alkyl, and a pharmaceutically acceptable acid addition salt thereof are disclosed.There is also disclosed a process for preparing the compounds according to formula I, pharmaceutical compositions containing the same as well as the use thereof. Said derivatives according to formula I as well as pharmaceutically acceptable salts thereof are useful as a hypotensive agent and/or a cerebral or coronary vasodilator.
Patent NO-861224-L (NO)
Inventor: LEHR ANDREAS JOSEPHUS
IPC: G10K1/32
Filed: 1986-03-26
Abstract: 1. Ringing or chiming bell comprising a lip (9), a shoulder (3) and a waist (7), having a weight in N which is at least 25 times the product of the frequency of the fundamental tone in Hertz and the diameter of the lip to the power four in metres, characterized in that a flank between the shoulder and the lip has an external outward curve (5) which runs smoothly outwards and, at both axial ends, merges via transitions curved in the opposite direction into the flank parts in the vicinity of the shoulder (3) and of the waist (7) respectively, in that the bell has a ratio, resulting from the outward curve (5), of the five lowest frequencies of 1:2:2.5:3:4 within the customary tolerances (0.5-1.5%), and in that reversal points (11, 12) which delimit the convex part of the outward curve (5) on the outside are situated at points which are at axial distances from the upper face (19) of the upper wall (1), which merges into the flank via the shoulder (3), any head (2) on the upper wall (1) not being taken into account, by a measure within the following limits : - for the reversal point (11) nearer to the shoulder (3), between 28 and 40% of the axial outside length (le) of the bell between this upper face (19) and the lower edge (9), - and for the reversal point (12) remote from the shoulder (3) : between 55 and 66% of this axial length (le).
Patent NO-883188-L (NO)
Inventor: PFAENDLER HANS ROLF
IPC: A61K31/42
Filed: 1988-07-18
Abstract: Compounds of the structural formulae  <IMAGE>  and their pharmaceutically acceptable salts, esters and amide derivatives, in which R1 and R2, independently of one another, denote hydrogen or pharmaceutically acceptable groups which have 1 to 10 carbon atoms and are bonded to the remaining part of the molecule via carbon-carbon single bonds, and in which R3, R4 and R5, independently of one another, denote pharmaceutically acceptable groups which have 1 to 10 carbon atoms and are bonded to the remaining part of the molecule via carbon-carbon single bonds, are useful antibiotics. The trisubstitution by three groups R3, R4 and R5, which are bonded via carbon-carbon single bonds, results in a noticeable increase in the hydrolysis stability and thus also in the antibacterial action of axapenemcarboxylic acids.
Patent NO-884147-L (NO)
Inventor: KONGSHAUG GUNNAR
IPC: B01D53/34
Filed: 1988-09-16
Abstract: The present invention relates to a method by reduction of nitrogen oxides in gas mixtures, especially removing/decomposition of nitrogen oxide in hot combustion gases. The hot gas mixture which contains N2O is given a retention time of 0.1-3 seconds before being cooled down. About 90% of N2O is hereby decomposed to N2 and O2. A hot gas mixture formed by catalytic combustion of ammonia is given a retention time of 0.5-2 seconds before it is cooled in a heat recovery unit. The combustion gases can also be brought in contact with a metal or metal oxide catalyst for selective decomposition of N2O.
Patent NO-893538-L (NO)
Inventor: GRIFFIN DON
IPC: A47J27/08
Filed: 1989-09-04
Abstract: A container useful in microwave heating of foods comprises a substrate with a titanium nitride film on at least a portion of the substrate, the substrate being substantially microwave transparent except where coated with the titanium nitride film and the film being adapted to absorb microwave energy so that in use the film becomes heated and transfers heat to foods carried by the container, so as to provide crisp heating of the foods.
Patent NO-901209-L (NO)
Inventor: UESUGI KEIZO
IPC: A61K31/405
Filed: 1990-03-15
Abstract: A polyprenyl compound having the formula (1) is stabilized with a tocopherol, an organic acid, a neutral amino acid or a basic amino acid: <CHEM> in which n is an integer of 1 to 3.
Patent NO-903078-L (NO)
Inventor: NADOR KAROLY
IPC: A61K31/54
Filed: 1990-07-10
Abstract: The invention relates to nitrogen- and sulfur-containing heterocyclic compounds of the formula (I), <CHEM>  wherein Ar      represents an optionally mono- or polysubstituted aryl or heteroaryl group;  R<1>      represents a carbonyl or (C2-6alkenyl)-carbonyl group; R<2>      represents a hydrogen atom, or a C1-6alkyl, phenyl or phenyl(C1-4alkyl) group; R<3>      represents a hydrogen atom or a (C1-6 alkoxy)carbonyl group; R<4> and R<5>,      which may be the same or different, represent a hydrogen atom or a C1-6alkyl group; R<6>      represents a hydrogen atom or a C1-6alkyl group or halophenyl group;  m      is 0 or 1; and  n is 1 or 2, with the proviso that R<2> is a hydrogen atom when m is 0, and acid addition salts of the compounds of formula (I) and pharmaceutical compositions thereof. The invention also relates to processes for the preparation of these compounds. The compounds of formula (I) show a significant cerebral antihypoxic activity.
Patent NO-910652-L (NO)
Inventor: TORGALKAR ANIL N
IPC: A61F5/445
Filed: 1991-02-19
Abstract: An ostomy bag having a stomal aperture to receive a stoma in one wall of the bag and a gas venting aperture in the bag with a filter element covering the gas venting aperture, the bag including an intervening membrane 40, 52, 58 disposed between the front rear walls 12, 14 of the bag and between the stomal aperture and the gas venting aperture 30. The intervening membrane is liquid impermeable and gas permeable and supports an adequate flow rate of gas for ostomy bag applications. The intervening membrane preferably comprises a polytetrafloroethylene, microporous semi-permeable membrane laminated to a thermoplastic film layer which is heat sealable to the walls of the bag. <IMAGE>
Patent NO-912041-L (NO)
Inventor: BOUIX ALAIN
IPC: H04W24/00
Filed: 1991-05-28
Abstract: This method is employed in an intelligent network including: 
 
  - a distribution network (1) consisting of: fixed stations (B1,...,Bp); an integrated services digital switched public network (2), each fixed station being connected thereto by telephone channels (30B) and by a user-to-user signalling channel (D); and cordless digital telephones (T1,...,Tn) connected by radio to the fixed stations; 
  - a service control points network (3) including network service control points (14, 15) connected to the switched public network (2); and a management service control point (16); 
 
<??>It consists in: 
 
  - transmitting from each station (B1,...,Bp) to a network service point (14, 15), a maintenance message, if the fixed station detects an incident, or if it receives an auto-test order; 
  - drawing up a maintenance slip, in the network service control point (14, 15); 
  - transmitting the said maintenance slip to the management service control point (16), and storing it in a database. 
 
<??>Application to the cordless telephone service. 
<IMAGE>